RemSleep Holdings Inc. (RMSL) stock: key figures, P/E, revenue and dividend

Consumer Discretionary · United States · ISIN US75990A2006

Price
0.00 USD
Market cap
2.09 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

RemSleep Holdings Inc. financials

Fiscal year2025
Revenue16,721.00 USD
Gross profit4,014.00 USD
Operating income-2.77 m USD
EBIT-2.63 m USD
Net income-3.02 m USD
Diluted EPS – continuing operations0.00 USD

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About RemSleep Holdings Inc.

REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.